306 related articles for article (PubMed ID: 6422861)
21. [Comparative study of cyproterone acetate and estramustine phosphate on the plasma levels of testosterone and gonadotrophic hormones in adenocarcinoma of the prostate].
Alfonso Sánchez M; Pérez Herrero F; Urrutia Avisrror M; Vega Wong J; Lago Montero A
Actas Urol Esp; 1986; 10(2):111-6. PubMed ID: 2942009
[No Abstract] [Full Text] [Related]
22. Effect of a steroidal alkylating agent (estramustine phosphate) in rat ventral prostate.
Høisaeter PA
Scand J Urol Nephrol Suppl; 1977; (46):1-72. PubMed ID: 279091
[No Abstract] [Full Text] [Related]
23. Continuous versus intermittent oral therapy with estramustine phosphate (Estracyt).
Vahlensieck W; Wegner G
Scand J Urol Nephrol Suppl; 1980; 55():147-9. PubMed ID: 6938018
[TBL] [Abstract][Full Text] [Related]
24. [The evaluation of the effect of Estracyt on prostatic cancer].
Fukuoka H; Ishibashi Y; Sakai N; Ogawa T; Satomi Y; Sugawara T; Kamimura H; Yamaguchi T; Kishida K; Shirai K
Hinyokika Kiyo; 1991 Jan; 37(1):91-7. PubMed ID: 2011974
[TBL] [Abstract][Full Text] [Related]
25. Testosterone-induced DNA synthesis in cultured rat ventral prostate: effects of estracyt and its derivatives.
Buchanan LJ; Riches AC
Br J Cancer; 1987 Jan; 55(1):47-51. PubMed ID: 3814475
[TBL] [Abstract][Full Text] [Related]
26. Studies on the conversion of oestradiol linked to a cytostatic agent (Estracyt) in various rat tissues.
Hoisaeter PA
Acta Endocrinol (Copenh); 1976 Jul; 82(3):661-72. PubMed ID: 947135
[TBL] [Abstract][Full Text] [Related]
27. Expression of an estramustine-binding associated protein in human lung cancer cell lines.
Bergh J; Björk P; Westlin JE; Nilsson S
Cancer Res; 1988 Aug; 48(16):4615-9. PubMed ID: 2840198
[TBL] [Abstract][Full Text] [Related]
28. [The phase IV studies with Estracyt in prostatic cancer].
Ohhori T; Kubo T; Akasaka T; Funyu T; Yagihashi Y; Kudo T; Tsuchida S; Harada T; Sasaki S; Orikasa S
Hinyokika Kiyo; 1988 Aug; 34(8):1493-502. PubMed ID: 3057833
[TBL] [Abstract][Full Text] [Related]
29. Metabolic aspects and actions unique to Estracyt.
Sandberg AA
Semin Oncol; 1983 Sep; 10(3 Suppl 3):3-15. PubMed ID: 6364364
[No Abstract] [Full Text] [Related]
30. Hormonal effects of different doses of estramustine phosphate (Estracyt) in patients with prostatic carcinoma.
Fritjofsson A; Norlén BJ; Högberg B; Rajalakshmi M; Cekan SZ; Diczfalusy E
Scand J Urol Nephrol; 1981; 15(1):37-44. PubMed ID: 6787701
[TBL] [Abstract][Full Text] [Related]
31. [Treatment of hormone-resistant prostate cancer with estramustine phosphate (Estracyt)].
Stridsklev IC; Fosså SD; Kaalhus O
Tidsskr Nor Laegeforen; 1984 Oct; 104(28):1977-80. PubMed ID: 6388019
[No Abstract] [Full Text] [Related]
32. On the effects of oestrogen in the male. Some effects of different oestrogenic substances in rats and men with prostatic carcinoma.
Daehlin L
Scand J Urol Nephrol Suppl; 1985; 91():1-44. PubMed ID: 3868029
[TBL] [Abstract][Full Text] [Related]
33. Binding sites for the cytotoxic metabolites of estramustine phosphate (Estracyt) in rat and human pancreas that are distinct from pancreatic estrogen-binding protein.
Björk P; Jönsson U; Andrén-Sandberg A
Pancreas; 1991 Jan; 6(1):77-89. PubMed ID: 1994382
[TBL] [Abstract][Full Text] [Related]
34. Plasma concentrations of estramustine phosphate and its major metabolites in patients with prostatic carcinoma treated with different doses of estramustine phosphate (Estracyt).
Gunnarsson PO; Forshell GP; Fritjofsson A; Norlén BJ
Scand J Urol Nephrol; 1981; 15(3):201-5. PubMed ID: 7323739
[TBL] [Abstract][Full Text] [Related]
35. Estracyt--mode of action and clinical experience.
Hedlund PO
Prog Clin Biol Res; 1987; 243B():215-9. PubMed ID: 3309981
[No Abstract] [Full Text] [Related]
36. Estramustine-binding protein in rat and human prostate.
Forsgren B
Scand J Urol Nephrol Suppl; 1988; 107():56-8. PubMed ID: 3287598
[TBL] [Abstract][Full Text] [Related]
37. Metabolic parameters of Estracyt pertinent to its effects in prostatic cancer.
Sandberg AA
Urology; 1984 Jun; 23(6 Suppl):11-21. PubMed ID: 6375075
[No Abstract] [Full Text] [Related]
38. [Clinical study of estramustine phosphate (Estracyt) on prostatic cancer].
Murase T; Mitsuya H; Honda N; Fukatu H; Aota Y; Shinoda M; Yoshida K; Sobajima T; Ohishi M; Tsumura Y
Hinyokika Kiyo; 1989 Jan; 35(1):179-85. PubMed ID: 2729015
[TBL] [Abstract][Full Text] [Related]
39. Estramustine phosphate (Estracyt): experimental and clinical studies in Europe.
Hoisaeter PA; Bakke A
Semin Oncol; 1983 Sep; 10(3 Suppl 3):27-33. PubMed ID: 6364363
[No Abstract] [Full Text] [Related]
40. Accumulation of estramustine and estromustine in adipose tissue of rats and humans.
Gunnarsson PO; Andersson SB; Sandberg AA; Ellman M
Cancer Chemother Pharmacol; 1991; 28(5):361-4. PubMed ID: 1914079
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
